Delivery Order V797D60737-75N90024F00080
- INO Therapeutics LLC, a Hazelwood, Missouri-based supplier of inhaled nitric oxide (INO) therapeutic gases and related medical services, was awarded a $321,643 firm fixed-price delivery order by Veterans Integrated Service Network 10 on April 27, 2022. This non-set-aside contract, with an ultimate completion date of April 26, 2027, falls under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) and represents a task order issued against a larger Indefinite Delivery/Indefinite...
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide therapeutic gases and respiratory therapy systems, was awarded a delivery order valued at $51,982.38 by Veterans Integrated Service Network 22, a civilian component of the Department of Veterans Affairs. The contract, issued March 1, 2024, with an ultimate completion date of February 28, 2025, operates under a firm fixed-price structure and is classified as a non-set-aside award. Performance will be executed at the...
- INO Therapeutics LLC, a Missouri-based supplier of specialized medical gases and respiratory therapy systems, was awarded a delivery order contract valued at $158,312 by the Defense Health Agency effective January 1, 2026, with completion targeted for December 31, 2026. This firm fixed-price delivery order procures inhaled nitric oxide (INOMAX) therapeutic gas and related inhalation therapy services for delivery to JBSA Fort Sam Houston in San Antonio, Texas. The contract carries no small...
- INO Therapeutics LLC, a Missouri-based supplier of specialized respiratory therapeutics, has been awarded a delivery order valued at $28,784 by the Department of Veterans Affairs Veterans Integrated Service Network 21 for the supply of INOMAX (nitric oxide) therapeutic gas and related inhalation therapy services. This delivery order, issued under a firm fixed-price arrangement with no set-aside designation, represents a child contract under the Pharmaceuticals and Drugs GSA Supply Schedule...
- INO Therapeutics LLC was awarded a delivery order valued at $341,058.70 by Veterans Integrated Service Network (VISN) 5 for the supply of inhaled nitric oxide (INO) therapeutic gas to the Nitric Oxide Division at the Durham VA Medical Center (VAMC). This firm fixed-price contract, awarded on March 16, 2020, with a completion date of March 15, 2025, represents a continuation of the company's primary service offering—specialized medical gas delivery to federal healthcare facilities. The award...
- The Defense Health Agency awarded a delivery order valued at $602,910 to INO Therapeutics LLC for 3,500 hours of inhaled nitric oxide (INO) therapy services, with an ultimate completion date of January 9, 2024. This firm fixed-price delivery order, issued under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB), represents a modification to an existing option year contract and does not utilize a set-aside designation. The work will be performed in Hampton, New Jersey, supporting the...
- The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a $10,794.00 delivery order to INO Therapeutics LLC on March 1, 2026, for the provision of nitric oxide gas services with an ultimate completion date of August 31, 2026. This is a firm fixed-price contract with no set-aside designation, issued as a child order under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB). The work will be performed in San Diego, California, supporting the VA's healthcare...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to INO Therapeutics LLC, a company that provides inhaled nitric oxide therapy systems and related medical gases. The contract is for the delivery of NITRIC OXIDE MEDICAL GAS with an ultimate completion date of September 30, 2024 and a ceiling value of $29,571.60. The contract was awarded without a set-aside designation and is under the Pharmaceuticals and Drugs GSA...
- Veterans Integrated Service Network 15 issued a delivery order to INO Therapeutics LLC on July 7, 2024, for INOMAX inhaled nitric oxide with delivery system, with a ceiling value of $413,879.32 under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB). Place of performance is Hazelwood, MO. The order extends through July 6, 2029. INO Therapeutics supplies inhaled nitric oxide therapeutic gas, INOMAX cylinders with delivery systems, and inhalation therapy services to federal...
- This is a delivery order awarded by the National Institutes of Health (NIH) to INO Therapeutics LLC, a foreign-owned for-profit organization. The $248,887.20 fixed-price contract is for the delivery of inhaled nitric oxide therapy systems and related medical gases to support respiratory treatments and healthcare programs for veterans, service members, and military beneficiaries. The contract was awarded under the General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D60737Federal Supply Schedule
- V797D60737-75N90024F00080Delivery Order
The National Institutes of Health Clinical Center awarded a $115,000 delivery order to INO Therapeutics LLC on July 1, 2024, to supply nitric oxide gas for treating critically ill patients in the Critical Care Medicine Department. The contract, which extends through February 28, 2027, is issued under a firm fixed-price structure with no small business set-aside designation. INO Therapeutics LLC, headquartered in Hazelwood, Missouri, specializes in providing inhaled nitric oxide therapeutic gases and respiratory therapy systems to federal healthcare agencies, including the Department of Veterans Affairs and Defense Health Agency. The delivery order is placed against the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB), with performance taking place in Hampton, New Jersey. This delivery order represents a continuation of INO Therapeutics' established role as a critical supplier of specialized medical gases to the federal healthcare system. The company maintains an extensive contract portfolio across multiple Veterans Integrated Service Networks and federal medical centers, with experience delivering nitric oxide gas supplies, INOMAX cylinders with delivery systems, and comprehensive inhalation therapy services. The vendor holds three active blanket purchase agreements that serve as parent vehicles for task order calls, including a Defense Health Agency BPA valued at $404,200 through March 2030 and a Veterans Affairs VISN 2 agreement valued at $789,408.92 through September 2027, enabling federal healthcare agencies to procure critical therapeutic gases on an as-needed basis to support patient care across neonatal, pediatric, and adult critical care populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $40.0k | 2/28/26 | |
| P00002 | Funding Only Action | $10.0k | 8/26/25 | |
| P00001 | Exercise an Option | $40.0k | 2/13/25 | |
| Not listed | Not listed | $25.0k | 7/1/24 |